111
Views
15
CrossRef citations to date
0
Altmetric
Case reports

Good response to IL‐1β blockade by anakinra in a 23‐year‐old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies

, , , , , , , & show all
Pages 385-389 | Accepted 11 Feb 2008, Published online: 12 Jul 2009

References

  • Prieur A. M. A recently recognized chronic inflammatory disease of early onset characterized by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 2001; 19: 103–6
  • Kallinich T., Hoffmann H. M., Roth J., Keitzer R. The clinical course of a child with CINCA/NOMID syndrome improved during and after treatment with thalidomide. Scand J Rheumatol 2005; 34: 246–9
  • OMIM (Online Mendelian Inheritance in Man). Database of human genes and genetic disorders. National Center for Biotechnology Information, Bethesda, MD 2006
  • Stojanov S., Kastner D. L. Familial autoinflammatory disease: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 586–99
  • Aksentijevich I., Nowak M., Mallah M., Chae J. J., Watford W. T., Hofmann S. R., et al. De novo CIAS1 mutations, cytokine activation, and evidence of genetic heterogeneitiy in patients with neonatal‐onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin‐associated autoinflammatory diseases. Arthritis Rheum 2002; 46: 3340–8
  • Agostini L., Martinson F., Burns K., McDermott, Hawkins P. N., Tschopp J. NALP3 forms an IL‐1β‐processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder. Immunity 2004; 20: 319–25
  • Goldbach‐Mansky R., Dailey N. J., Canna S. W., Gelabert A., Jones J., Rubin B., et al. Neonatal‐onset multisystemic inflammatory disease responsive to interleukin‐1β inhibition. N Engl J Med 2006; 10: 581–92
  • Lovell D. J., Bowyer S. L., Solinger A. M. IL‐1 blockade by anakinra improves clinical symptoms in patients with NOMID. Arthritis Rheum 2005; 52: 1283–6
  • Frenkel J., Wulffraat N. M., Kuis W. Anakinra in mutation negative NOMID/CINCA syndrome. Arthritis Rheum 2004; 50: 3738–9
  • Granel B., Serratrice J., Disdier P., Weiller P. J. Dramatic improvement with anakinra in a case of CINCA syndrome. Rheumatology 2005; 44: 689–90
  • Hawkins P. N., Lachmann H. J., Aganna E., McDermott M. F. Spectrum of clinical features in Muckle–Wells syndrome and response to anakinra. Arthritis Rheum 2004; 50: 607–12
  • Fiala M., Cribbs D. H., Rosenthal M., Bernard G. Phagocytosis of amyloid‐beta and inflammation: two faces of innate immunity in Alzheimer's disease. J Alzheimers Dis 2007; 11: 457–63
  • Dhenain M., El Tannir El Tayara N., Wu TD., Guegan M., Volk A., et al. Characterization of in vivo MRI detectable thalamic amyloid plaques from AAP/PS1 mice. Neurobiol Aging 2007 June, (Epub ahead of print) doi:10.1016/j.neurobiolaging.2007.05.018
  • Shintani S., Fumimura Y., Shiigai T. Acute disseminated encephalomyelitis following aseptic meningoencephalitis. Clin Neurol Neurosurg 2001; 103: 155–9
  • Goutières F. Aicardi–Goutières syndrome. Brain Dev 2005; 27: 201–6
  • Grosso S., Balestri P., Mostardini R., Federico A., De Stefoano N. Brain mitochondrial impairment in ethylmalonic encephalopathy. J Neurol 2004; 251: 755–6
  • Barnérias C., Giurgea I., Hertz‐Pannier L., Bahi‐Buisson N., Boddaert N., Rustin P., et al. Respiratory chain deficiency in a female with Aicardi–Goutières syndrome. Dev Med Child Neurol 2006; 48: 227–30
  • Hayflick S. J. Pathotenate kinase‐associated neurodegeration (formerly Hallervorden–Spatz syndrome). J Neurol Sci 2003; 207: 106–7
  • Dinarello C. A. Interleukin‐1, interleukin‐1 receptors and interleukin‐1 receptor antagonist. Int Rev Immunol 1998; 16: 457–99
  • Benveniste E. N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992; 263: C1–16

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.